IO Biotech Inc. announced that Brian Burkavage will resign as Senior Vice President and Chief Accounting Officer, effective December 12, 2025. Amy Sullivan, currently the company's Chief Financial Officer, has been appointed as the new principal accounting officer following his departure.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IO Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-291504), on November 21, 2025, and is solely responsible for the information contained therein.